Reporting Manager
Nextech Crossover I GP S.a. r.l.
Symbol
ORIC
Shares outstanding
85,269,488 shares
Disclosed Ownership
7,162,637 shares
Ownership
8.4%
Form type
SCHEDULE 13G/A
Filing time
14 Aug 2025, 16:54:59 UTC
Date of event
30 Jun 2025

Key filing fact

Nextech Crossover I GP S.a r.l. disclosed 8.4% ownership in ORIC Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (ORIC) on 30 Jun 2025.

Key facts

  • Nextech Crossover I GP S.a r.l. filed SCHEDULE 13G/A for ORIC Pharmaceuticals, Inc. Common Stock, $0.0001 par value per share (ORIC).
  • Disclosed ownership: 8.4%.
  • Date of event: 30 Jun 2025.

Change

  • No earlier schedule filing is available for direct comparison.
  • Current filing was accepted on 14 Aug 2025, 16:54.

Research use

  • This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
  • You can verify ownership claims directly against the original SEC filing.

Evidence

Backed by Schedule 13D/13G

Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.

See Original Filing

Reporting persons

Reporting managers (5)

Names, ownership, voting power, signatures, titles, and CIKs as disclosed in this Schedule 13D/G filing.

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Nextech Crossover I GP S.a. r.l. 8.4% 7,162,637 7,162,637 0 /s/ Ian Charoub By Ian Charoub, Manager
Nextech Crossover I SCSp 8.4% 7,162,637 7,162,637 0 /s/ Ian Charoub By Nextech Crossover I GP S.a r.l., its General Partner, By Ian Charoub, Manager
Ian Charoub 8.4% 7,162,637 0 7,162,637 /s/ Ian Charoub Ian Charoub
Costas Constantinides 8.4% 7,162,637 0 7,162,637 /s/ Costas Constantinides Costas Constantinides
Rocco Sgobbo 8.4% 7,162,637 7,162,637 0 /s/ Rocco Sgobbo Rocco Sgobbo
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .